Skip to main content

Search Results for

“电报老频道购买✅SMMFS.COM✅在线真人粉僵尸,BiO”

April 8, 2019

Awards The Osteoporosis Canada Tim Murray Short-Term Training Awards These awards provide individuals with the opportunity to learn more about osteoporosis, advance existing research skills in osteoporosis and/or present their […]

April 3, 2024

Latest News Nine Drug Formularies In Canada List Evenity® For Reimbursement For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk Of Fracture April 3, 2024 Amgen Canada has […]

January 28, 2021

HARRY K. GENANT, MD (1942-2021) Osteoporosis Canada is saddened to announce the passing of Dr. Harry K. Genant, internationally renowned for his ground-breaking research in non-invasive and quantitative imaging methods […]

April 8, 2019

Frequently Asked Questions What causes osteoporosis? No single cause for osteoporosis has been identified. However, certain factors – called risk factors – do seem to play a role in the […]

May 16, 2020

By Aliya Khan MD, FRCPC, FACP, FACE, Rowena Ridout MD FRCPC, Heather Frame MD FCFP, Claudia Gagnon MD, Lianne Tile MD MEd FRCPC, Wendy Ward M.Sc., Ph.D., David A. Hanley, […]

November 4, 2021

MEET THE CMC FACULTY Dr. Cathy Craven University of Toronto  Toronto, ON Cathy Craven is the Toronto Rehabilitation Institute/ University of Toronto Chair in Spinal Cord Injury (SCI) Rehabilitation, Professor […]

September 26, 2023

CMC 2023 The Canadian Musculoskeletal Conference (CMC) hosted by Osteoporosis Canada is November 23 and 24, 2023. Led by national and international experts in osteoporosis, this dynamic conference will offer […]

June 7, 2019

Board of Directors Jeannette Briggs Chair | Oakville, ON Jeannette has more than 25 years of experience working in the energy sector.  She has held a wide-range of jobs within […]

May 31, 2024

Latest News Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis. May 31, 2024 Health Canada has provided authorization to market Jubbonti® (denosumab […]

© Osteoporosis Canada, 2024
Charitable Registration No. 89551 0931 RR 0001